The Emerging Pathogen Candida metapsilosis: Biological Aspects, Virulence Factors, Diagnosis, and Treatment

References

• Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol. 2007;45(11):3522–3528. doi:10.1128/jcm.00403-07
   PubMed Web of Science ®Google Scholar
• Hani U, Shivakumar HG, Vaghela R, Osmani RA, Shrivastava A. Candidiasis: a fungal infection-current challenges and progress in prevention and treatment. Infect Disord Drug Targets. 2015;15(1):42–52. doi:10.2174/1871526515666150320162036
   PubMedGoogle Scholar
• Arendrup M, Horn T, Frimodt-Møller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection. 2002;30(5):286–291. doi:10.1007/s15010-002-2131-0
   PubMed Web of Science ®Google Scholar
• Pfaller M, Neofytos D, Diekema D, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis. 2012;74(4):323–331. doi:10.1016/j.diagmicrobio.2012.10.003
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Mendez M, et al. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol. 2006;44(10):3551–3556. doi:10.1128/JCM.00865-06
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis. 1998;30(2):121–129. doi:10.1016/S0732-8893(97)00192-2
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/421946
   PubMed Web of Science ®Google Scholar
• Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis. 2004;38(3):311–320. doi:10.1086/380637
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and mechanisms of antifungal resistance. Antibiotics. 2020;9(6):312. doi:10.3390/antibiotics9060312
   Google Scholar
• Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–1971. doi:10.1016/S0140-6736(07)60917-9
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother. 2000;44(3):747–751. doi:10.1128/aac.44.3.747-751.2000
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol. 2008;46(8):2659–2664. doi:10.1128/JCM.00803-08
   PubMed Web of Science ®Google Scholar
• Tosun I, Akyuz Z, Guler NC, et al. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples. Med Mycol. 2013;51(5):483–492. doi:10.3109/13693786.2012.745953
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1):e1000713. doi:10.1371/journal.ppat.1000713
   PubMed Web of Science ®Google Scholar
• Canton E, Peman J, Quindos G, et al. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother. 2011;55(12):5590–5596. doi:10.1128/AAC.00466-11
   PubMed Web of Science ®Google Scholar
• Pryszcz LP, Nemeth T, Saus E, et al. The genomic aftermath of hybridization in the opportunistic pathogen Candida metapsilosis. PLoS Genet. 2015;11(10):e1005626. doi:10.1371/journal.pgen.1005626
   PubMed Web of Science ®Google Scholar
• Gago S, García-Rodas R, Cuesta I, Mellado E, Alastruey-Izquierdo A. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella. Virulence. 2014;5(2):278–285. doi:10.4161/viru.26973
   PubMed Web of Science ®Google Scholar
• Arastehfar A, Khodavaisy S, Daneshnia F, et al. Molecular identification, genotypic diversity, antifungal susceptibility, and clinical outcomes of infections caused by clinically underrated yeasts, Candida orthopsilosis, and Candida metapsilosis: an Iranian multicenter study (2014–2019) Original Research. Front Cell Infect Microbiol. 2019;9:264. doi:10.3389/fcimb.2019.00264
   PubMed Web of Science ®Google Scholar
• Feng X, Wu Z, Ling B, et al. Identification and differentiation of Candida parapsilosis complex species by use of exon-primed intron-crossing PCR. J Clin Microbiol. 2014;52(5):1758–1761. doi:10.1128/JCM.00105-14
   PubMed Web of Science ®Google Scholar
• Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21(4):606–625. doi:10.1128/CMR.00013-08
   PubMed Web of Science ®Google Scholar
• Lackey E, Vipulanandan G, Childers DS, Kadosh D. Comparative evolution of morphological regulatory functions in Candida species. Eukaryot Cell. 2013;12(10):1356–1368. doi:10.1128/EC.00164-13
   PubMedGoogle Scholar
• Melo AS, Bizerra FC, Freymüller E, Arthington-Skaggs BA, Colombo AL. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011;49(3):253–262. doi:10.3109/13693786.2010.530032
   PubMed Web of Science ®Google Scholar
• Gómez-Gaviria M, García-Carnero LC, Tamez-Castrellón AK, Mora-Montes HM. The cell wall of medically relevant yeasts and molds. In: Zaragoza Ó, Casadevall A, editors. Encyclopedia of Mycology. Elsevier. Elsevier; 2021:12–22.
   Google Scholar
• Díaz-Jiménez DF, Pérez-García LA, Martínez-álvarez JA, Mora-Montes HM. Role of the fungal cell wall in pathogenesis and antifungal resistance. Curr Fungal Infect Rep. 2012;6(4):275–282. doi:10.1007/s12281-012-0109-7
   Google Scholar
• Klis FM, de Groot P, Hellingwerf K. Molecular organization of the cell wall of Candida albicans. Med Mycol. 2001;39(Suppl 1):1–8. doi:10.1080/mmy.39.1.1.8-0
   PubMed Web of Science ®Google Scholar
• Estrada-Mata E, Navarro-Arias MJ, Perez-Garcia LA, et al. Members of the Candida parapsilosis complex and Candida albicans are differentially recognized by human peripheral blood mononuclear cells. Front Microbiol. 2016;6:1527. doi:10.3389/fmicb.2015.01527
   PubMed Web of Science ®Google Scholar
• Shibata N, Ikuta K, Imai T, et al. Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J Biol Chem. 1995;270(3):1113–1122. doi:10.1074/jbc.270.3.1113
   PubMed Web of Science ®Google Scholar
• Valach M, Pryszcz LP, Tomaska L, Gacser A, Gabaldón T, Nosek J. Mitochondrial genome variability within the Candida parapsilosis species complex. Mitochondrion. 2012;12(5):514–519. doi:10.1016/j.mito.2012.07.109
   PubMed Web of Science ®Google Scholar
• Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43(1):284–292. doi:10.1128/JCM.43.1.284-292.2005
   PubMed Web of Science ®Google Scholar
• Toth R, Nosek J, Mora-Montes HM, et al. Candida parapsilosis: from genes to the bedside. Clin Microbiol Rev. 2019;32(2). doi:10.1128/CMR.00111-18
   PubMed Web of Science ®Google Scholar
• Rycovska A, Valach M, Tomaska L, Bolotin-Fukuhara M, Nosek J. Linear versus circular mitochondrial genomes: intraspecies variability of mitochondrial genome architecture in Candida parapsilosis. Microbiology. 2004;150(Pt 5):1571–1580. doi:10.1099/mic.0.26988-0
   PubMedGoogle Scholar
• Kosa P, Valach M, Tomaska L, Wolfe KH, Nosek J. Complete DNA sequences of the mitochondrial genomes of the pathogenic yeasts Candida orthopsilosis and Candida metapsilosis: insight into the evolution of linear DNA genomes from mitochondrial telomere mutants. Nucleic Acids Res. 2006;34(8):2472–2481. doi:10.1093/nar/gkl327
   PubMed Web of Science ®Google Scholar
• Sai S, Holland LM, McGee CF, Lynch DB, Butler G. Evolution of mating within the Candida parapsilosis species group. Eukaryot Cell. 2011;10(4):578–587. doi:10.1128/EC.00276-10
   PubMedGoogle Scholar
• Guérin M, Camougrand N. The alternative oxidase of Candida parapsilosis. Eur J Biochem. 1986;159(3):519–524. doi:10.1111/j.1432-1033.1986.tb09917.x
   PubMedGoogle Scholar
• Cordeiro RA, Sales JA, Ponte YB, et al. Phenotype-driven strategies for screening Candida parapsilosis complex for molecular identification. Braz J Microbiol. 2018;49(Suppl 1):193–198. doi:10.1016/j.bjm.2017.11.004
   PubMedGoogle Scholar
• Bednarek M, Szwengiel A, Flórez AB, Czarnecki Z, Mayo B. Effect of different starter cultures on chemical and microbial parameters of buckwheat honey fermentation. Food Microbiol. 2019;82:294–302. doi:10.1016/j.fm.2019.03.006
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhou W, Yang Z, et al. A critical assessment of the Candida strains isolated from cigar tobacco leaves. Front Bioeng Biotechnol. 2023;11:1201957. doi:10.3389/fbioe.2023.1201957
   PubMed Web of Science ®Google Scholar
• Gacser A. Adhesins in Candida parapsilosis: understudied players in virulence. Virulence. 2016;7(2):65–67. doi:10.1080/21505594.2015.1135288
   PubMed Web of Science ®Google Scholar
• de Groot PW, Bader O, de Boer AD, Weig M, Chauhan N. Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryot Cell. 2013;12(4):470–481. doi:10.1128/ec.00364-12
   PubMed Web of Science ®Google Scholar
• Cota E, Hoyer LL. The Candida albicans agglutinin-like sequence family of adhesins: functional insights gained from structural analysis. Future Microbiol. 2015;10(10):1635. doi:10.2217/fmb.15.79
   PubMed Web of Science ®Google Scholar
• Oh SH, Smith B, Miller AN, et al. Agglutinin-like sequence (ALS) genes in the Candida parapsilosis species complex: blurring the boundaries between gene families that encode cell-wall proteins. Front Microbiol. 2019;10:781. doi:10.3389/fmicb.2019.00781
   PubMed Web of Science ®Google Scholar
• Lombardi L, Zoppo M, Rizzato C, et al. Characterization of the Candida orthopsilosis agglutinin-like sequence (ALS) genes. PLoS One. 2019;14(4):e0215912. doi:10.1371/journal.pone.0215912
   PubMed Web of Science ®Google Scholar
• Essen LO, Vogt MS, Mösch HU. Diversity of GPI-anchored fungal adhesins. Biol Chem. 2020;401(12):1389–1405. doi:10.1515/hsz-2020-0199
   PubMed Web of Science ®Google Scholar
• Bertini A, De Bernardis F, Hensgens LA, Sandini S, Senesi S, Tavanti A. Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity. Int J Med Microbiol. 2013;303(2):98–103. doi:10.1016/j.ijmm.2012.12.006
   PubMed Web of Science ®Google Scholar
• Talapko J, Juzbašić M, Matijević T, et al. Candida albicans-the virulence factors and clinical manifestations of infection. J Fungi. 2021;7(2):79. doi:10.3390/jof7020079
   Web of Science ®Google Scholar
• Araújo D, Henriques M, Silva S. Portrait of Candida species biofilm regulatory network genes. Trends Microbiol. 2017;25(1):62–75. doi:10.1016/j.tim.2016.09.004
   PubMed Web of Science ®Google Scholar
• Pulcrano G, Panellis D, De Domenico G, Rossano F, Catania MR, Calderone R. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm. FEMS Yeast Res. 2012;12(4):430–438. doi:10.1111/j.1567-1364.2012.00792.x
   PubMed Web of Science ®Google Scholar
• Paula-Mattiello S, Oliveira SD, Medina-Silva R. In vitro evaluation of hydrolytic enzyme activity and biofilm formation of Candida parapsilosis species complex from a nosocomial environment. Rev Soc Bras Med Trop. 2017;50(4):558–561. doi:10.1590/0037-8682-0032-2017
   PubMed Web of Science ®Google Scholar
• Modiri M, Khodavaisy S, Barac A, et al. Comparison of biofilm-producing ability of clinical isolates of Candida parapsilosis species complex. J Mycol Med. 2019;29(2):140–146. doi:10.1016/j.mycmed.2019.02.003
   PubMed Web of Science ®Google Scholar
• Lattif AA, Mukherjee PK, Chandra J, et al. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int J Med Microbiol. 2010;300(4):265–270. doi:10.1016/j.ijmm.2009.09.001
   PubMed Web of Science ®Google Scholar
• de Toro M, Torres MJ, Maite R, Aznar J. Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect. 2011;17(3):418–424. doi:10.1111/j.1469-0691.2010.03302.x
   PubMed Web of Science ®Google Scholar
• Melo AS, Colombo AL, Arthington-Skaggs BA. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother. 2007;51(9):3081–3088. doi:10.1128/aac.00676-07
   PubMed Web of Science ®Google Scholar
• Treviño-Rangel Rde J, Rodríguez-Sánchez IP, Rosas-Taraco AG, Hernández-Bello R, González JG, González GM. Biofilm formation and genetic variability of BCR1 gene in the Candida parapsilosis complex. Rev Iberoam Micol. 2015;32(3):180–184. doi:10.1016/j.riam.2014.11.001
   PubMed Web of Science ®Google Scholar
• Gácser A, Schäfer W, Nosanchuk JS, Salomon S, Nosanchuk JD. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol. 2007;44(12):1336–1341. doi:10.1016/j.fgb.2007.02.002
   PubMed Web of Science ®Google Scholar
• Treviño-Rangel R, González-González JG, Garza-González E, González GM. Candida parapsilosis, una amenaza desafiante. Medicina Universitaria. 2012;14(56):157–165.
   Google Scholar
• Gómez-Gaviria M, Mora-Montes HM. Current aspects in the biology, pathogeny, and treatment of Candida krusei, a neglected fungal pathogen. Infect Drug Resist. 2020;13:1673–1689. doi:10.2147/idr.S247944
   PubMed Web of Science ®Google Scholar
• Souza ACR, Fuchs BB, Alves VS, Jayamani E, Colombo AL, Mylonakis E. Pathogenesis of the Candida parapsilosis complex in the model host Caenorhabditis elegans. Genes. 2018;9(8):401. doi:10.3390/genes9080401
   PubMed Web of Science ®Google Scholar
• Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48(6):365–377. doi:10.1111/j.1439-0507.2005.01165.x
   PubMed Web of Science ®Google Scholar
• Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol. 2000;38(12):4626–4628. doi:10.1128/jcm.38.12.4626-4628.2000
   PubMed Web of Science ®Google Scholar
• Ge YP, Lu GX, Shen YN, Liu WD. In vitro evaluation of phospholipase, proteinase, and esterase activities of Candida parapsilosis and Candida metapsilosis. Mycopathologia. 2011;172(6):429–438. doi:10.1007/s11046-011-9440-8
   PubMed Web of Science ®Google Scholar
• Hensgens LA, Tavanti A, Mogavero S, Ghelardi E, Senesi S. AFLP genotyping of Candida metapsilosis clinical isolates: evidence for recombination. Fungal Genet Biol. 2009;46(10):750–758. doi:10.1016/j.fgb.2009.06.006
   PubMed Web of Science ®Google Scholar
• da Silva BV, Silva LB, de Oliveira DB, et al. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates recovered from clinical specimens. Mycopathologia. 2015;180(5–6):333–343. doi:10.1007/s11046-015-9916-z
   PubMed Web of Science ®Google Scholar
• Tay ST, Na SL, Chong J. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J Med Microbiol. 2009;58(Pt 2):185–191. doi:10.1099/jmm.0.004242-0
   PubMed Web of Science ®Google Scholar
• Mirhendi H, Bruun B, Schønheyder HC, et al. Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. J Med Microbiol. 2010;59(Pt 4):414–420. doi:10.1099/jmm.0.017293-0
   PubMed Web of Science ®Google Scholar
• Mendoza-Reyes DF, Gómez-Gaviria M, Mora-Montes HM. Candida lusitaniae: biology, pathogenicity, virulence factors, diagnosis, and treatment. Infect Drug Resist. 2022;15:5121–5135. doi:10.2147/idr.S383785
   PubMed Web of Science ®Google Scholar
• Martinez-Alvarez JA, Perez-Garcia LA, Flores-Carreon A, et al. The immune response against Candida spp. and Sporothrix schenckii. Rev Iberoam Micol. 2014;31(1):62–66. doi:10.1016/j.riam.2013.09.015
   PubMed Web of Science ®Google Scholar
• Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. Immune defence against Candida fungal infections. Nat Rev Immunol. 2015;15(10):630–642. doi:10.1038/nri3897
   PubMed Web of Science ®Google Scholar
• Hernandez-Chavez MJ, Perez-Garcia LA, Nino-Vega GA, Mora-Montes HM. Fungal strategies to evade the host immune recognition. J Fungi. 2017;3(4):51. doi:10.3390/jof3040051
   Web of Science ®Google Scholar
• Gómez-Gaviria M, Vargas-Macías AP, García-Carnero LC, Martínez-Duncker I, Mora-Montes HM. Role of protein glycosylation in interactions of medically relevant fungi with the host. J Fungi. 2021;7(10):875. doi:10.3390/jof7100875
   Web of Science ®Google Scholar
• Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest. 2006;116(6):1642–1650. doi:10.1172/JCI27114
   PubMed Web of Science ®Google Scholar
• Dennehy KM, Ferwerda G, Faro-Trindade I, et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol. 2008;38(2):500–506. doi:10.1002/eji.200737741
   PubMed Web of Science ®Google Scholar
• Yadav B, Mora-Montes HM, Wagener J, et al. Differences in fungal immune recognition by monocytes and macrophages: n-mannan can be a shield or activator of immune recognition. Cell Surf. 2020;6:100042. doi:10.1016/j.tcsw.2020.100042
   PubMedGoogle Scholar
• Orsi CF, Colombari B, Blasi E. Candida metapsilosis as the least virulent member of the ‘C. parapsilosis’ complex. Med Mycol. 2010;48(8):1024–1033. doi:10.3109/13693786.2010.489233
   PubMed Web of Science ®Google Scholar
• Feng X, Ling B, Yang G, Yu X, Ren D, Yao Z. Prevalence and distribution profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis responsible for superficial candidiasis in a Chinese university hospital. Mycopathologia. 2012;173(4):229–234. doi:10.1007/s11046-011-9496-5
   PubMed Web of Science ®Google Scholar
• Barbedo LS, Vaz C, Pais C, et al. Different scenarios for Candida parapsilosis fungaemia reveal high numbers of mixed C. parapsilosis and Candida orthopsilosis infections. J Med Microbiol. 2015;64(Pt 1):7–17. doi:10.1099/jmm.0.080655-0
   PubMedGoogle Scholar
• Oliveira VK, Paula CR, Colombo AL, et al. Candidemia and death by Candida orthopsilosis and Candida metapsilosis in neonates and children. Pediatr Neonatol. 2014;55(1):75–76. doi:10.1016/j.pedneo.2013.07.006
   PubMed Web of Science ®Google Scholar
• De Carolis E, Hensgens LA, Vella A, et al. Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs AFLP. Med Mycol. 2014;52(2):123–130. doi:10.1093/mmy/myt009
   PubMed Web of Science ®Google Scholar
• Ghelardi E, Pichierri G, Castagna B, Barnini S, Tavanti A, Campa M. Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species. Clin Microbiol Infect. 2008;14(2):141–147. doi:10.1111/j.1469-0691.2007.01872.x
   PubMed Web of Science ®Google Scholar
• Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods. 2015;111:50–56. doi:10.1016/j.mimet.2015.02.004
   PubMed Web of Science ®Google Scholar
• Willemsen M, Breynaert J, Lauwers S. Comparison of Auxacolor with API 20 C Aux in yeast identification. Clin Microbiol Infect. 1997;3(3):369–375. doi:10.1111/j.1469-0691.1997.tb00628.x
   PubMedGoogle Scholar
• Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect. 2011;17(9):1359–1365. doi:10.1111/j.1469-0691.2010.03398.x
   PubMed Web of Science ®Google Scholar
• Garcia-Effron G, Canton E, Pemán J, Dilger A, Romá E, Perlin DS. Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species. J Clin Microbiol. 2011;49(9):3257–3261. doi:10.1128/jcm.00508-11
   PubMed Web of Science ®Google Scholar
• Arastehfar A, Fang W, Pan W, Liao W, Yan L, Boekhout T. Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR. BMC Infect Dis. 2018;18(1):480. doi:10.1186/s12879-018-3381-5
   PubMedGoogle Scholar
• Quiles-Melero I, García-Rodríguez J, Gómez-López A, Mingorance J. Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis. Eur J Clin Microbiol Infect Dis. 2012;31(1):67–71. doi:10.1007/s10096-011-1277-z
   PubMed Web of Science ®Google Scholar
• Souza AC, Ferreira RC, Gonçalves SS, et al. Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR. J Clin Microbiol. 2012;50(7):2310–2314. doi:10.1128/jcm.00303-12
   PubMed Web of Science ®Google Scholar
• Gomez-Lopez A, Alastruey-Izquierdo A, Rodriguez D, et al. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother. 2008;52(4):1506–1509. doi:10.1128/aac.01595-07
   PubMed Web of Science ®Google Scholar
• Bennett JE. Echinocandins for candidemia in adults without neutropenia. N Engl J Med. 2006;355(11):1154–1159. doi:10.1056/NEJMct060052
   PubMed Web of Science ®Google Scholar
• Douglas CM, Foor F, Marrinan JA, et al. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. Proc Natl Acad Sci U S A. 1994;91(26):12907–12911. doi:10.1073/pnas.91.26.12907
   PubMed Web of Science ®Google Scholar
• Douglas CM, D’Ippolito JA, Shei GJ, et al. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother. 1997;41(11):2471–2479. doi:10.1128/aac.41.11.2471
   PubMed Web of Science ®Google Scholar
• Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat. 2007;10(3):121–130. doi:10.1016/j.drup.2007.04.002
   PubMed Web of Science ®Google Scholar
• Katiyar S, Pfaller M, Edlind T. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2006;50(8):2892–2894. doi:10.1128/aac.00349-06
   PubMed Web of Science ®Google Scholar
• Spreghini E, Orlando F, Tavanti A, et al. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis. J Antimicrob Chemother. 2012;67(9):2195–2202. doi:10.1093/jac/dks180
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Boyken LB, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol. 2009;47(10):3170–3177. doi:10.1128/jcm.00942-09
   PubMed Web of Science ®Google Scholar
• Földi R, Kovács R, Gesztelyi R, et al. Comparison of in vitro and vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans. Mycopathologia. 2012;174(4):311–318. doi:10.1007/s11046-012-9554-7
   PubMed Web of Science ®Google Scholar
• Sarvikivi E, Lyytikäinen O, Soll DR, et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol. 2005;43(6):2729–2735. doi:10.1128/jcm.43.6.2729-2735.2005
   PubMed Web of Science ®Google Scholar
• Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother. 2007;59(4):767–771. doi:10.1093/jac/dkl555
   PubMed Web of Science ®Google Scholar